CWA
ABBV icon

Clearview Wealth Advisors’s AbbVie ABBV Stock Holding History

Clearview Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$821K Sell
3,595
-159
-4% -$36.2K 0.52% 43
2025
Q3 		$869K Sell
3,754
-93
-2% -$18.9K 0.56% 41
2025
Q2 		$714K Sell
3,847
-9
-0.2% -$1.67K 0.5% 43
2025
Q1 		$808K Sell
3,856
-128
-3% -$24.9K 0.6% 34
2024
Q4 		$708K Sell
3,984
-34
-0.8% -$6.25K 0.54% 40
2024
Q3 		$794K Sell
4,018
-106
-3% -$19.8K 0.61% 37
2024
Q2 		$707K Sell
4,124
-177
-4% -$29.3K 0.62% 36
2024
Q1 		$783K Sell
4,301
-129
-3% -$22.2K 0.8% 30
2023
Q4 		$687K Buy
4,430
+18
+0.4% +$2.62K 0.8% 44
2023
Q3 		$658K Sell
4,412
-351
-7% -$51.5K 0.81% 46
2023
Q2 		$642K Sell
4,763
-54
-1% -$7.92K 0.65% 45
2023
Q1 		$768K Sell
4,817
-1,833
-28% -$280K 0.78% 32
2022
Q4 		$1.07M Buy
6,650
+27
+0.4% +$4.14K 0.83% 26
2022
Q3 		$889K Buy
6,623
+204
+3% +$29.3K 0.7% 24
2022
Q2 		$983K Buy
6,419
+144
+2% +$22K 0.74% 23
2022
Q1 		$1.02M Sell
6,275
-148
-2% -$21.5K 0.67% 26
2021
Q4 		$870K Buy
6,423
+293
+5% +$34.6K 0.53% 44
2021
Q3 		$661K Sell
6,130
-353
-5% -$40.3K 0.42% 53
2021
Q2 		$730K Buy
6,483
+381
+6% +$42.9K 0.45% 49
2021
Q1 		$660K Buy
6,102
+608
+11% +$65K 0.43% 53
2020
Q4 		$589K Buy
+5,494
New +$528K 0.4% 56

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Clearview Wealth Advisors's ABBV Position: Q4 2025 in Review

Clearview Wealth Advisors reduced its AbbVie (ABBV) stake by 4.2% in Q4 2025, selling an estimated $36.2K and leaving 3,595 shares worth $821K. The position accounts for 0.52% of the portfolio, ranked #43.

Clearview Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.07M in Q4 2022. 4,160 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Clearview Wealth Advisors held 3,595 shares of AbbVie worth $821K as of Q4 2025.
  • Clearview Wealth Advisors sold 159 AbbVie shares in Q4 2025, an estimated $36.2K.
  • AbbVie made up 0.52% of Clearview Wealth Advisors's portfolio in Q4 2025, its #43 holding.
  • Clearview Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • Clearview Wealth Advisors's AbbVie position peaked at $1.07M in Q4 2022.
  • 4,160 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Clearview Wealth Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.